Timothy P. Clackson's most recent trade in Elevation Oncology Inc was a trade of 47,330 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on July 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevation Oncology Inc | Timothy P. Clackson | Director | 23 Jul 2025 | 47,330 | 0 | - | 0.4 | 17,039 | Common Stock | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 31,238 | 0 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Jul 2025 | 15,619 | 0 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | 05 Jun 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | ||
| Elevation Oncology Inc | Timothy P. Clackson | Director | 13 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | ||
| Elevation Oncology Inc | Timothy P. Clackson | Director | 16 Jun 2023 | 31,238 | 31,238 | - | - | Stock Option (Right to Buy) | ||
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 45,625 | 45,625 | - | - | Restricted Stock Units | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 273,750 | 273,750 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 11 Nov 2022 | 2,500 | 351,030 | - | 6.8 | 16,995 | Common Stock |
| Elevation Oncology Inc | Timothy P. Clackson | Director | 17 Jun 2022 | 31,553 | 15,777 | - | 0 | Common Stock | ||
| Elevation Oncology Inc | Timothy P. Clackson | Director | 17 Jun 2022 | 15,619 | 15,619 | - | - | Stock Option (Right to Buy) | ||
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.76 per share. | 21 Dec 2021 | 2,600 | 348,530 | - | 9.8 | 25,381 | Common Stock |